Disturbance of activity and attention

F5_ADHD

attention deficit hyperactivity disorder: A mental disorder characterized by inattention, easy distraction, careless mistakes and avoidance of tasks that require sustained mental focus. These behaviors can lead to maladaptive consequences in the affected individual's life.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F90.0 Hospital discharge: ICD-9 — 3140 Cause of death: ICD-10 — F90.0 Cause of death: ICD-9 — 3140 2 out of 7 registries used, show all original rules.	4749
4. Check minimum number of events None	4749
5. Include endpoints None	4749
6. Filter based on genotype QC (FinnGen only)	4749

Control definitions (FinnGen only)

Control exclude: F5_BEHEMOCHILD

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: F90
Name in latin: Perturbatio activitatis et attentionis

NAME	F5_ADHD
CONTROL_EXCLUDE	F5_BEHEMOCHILD
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F900
HD_ICD_9	3140
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F900
COD_ICD_9	3140
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Disturbance of activity and attention based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	77869	25797	51869
Only index persons	66365	23316	43049
Unadjusted period prevalence (%)
Whole population	1.21	0.74	1.45
Only index persons	1.37	0.86	1.64
Median age at first event (years)
Whole population	13.73	19.60	10.73
Only index persons	15.50	21.50	12.24

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4749	2941	1808
Unadjusted period prevalence (%)	0.92	1.00	0.80
Median age at first event (years)	29.87	31.26	27.62

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3922: Matched controls
38931

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

8.4

323.0

1668

3154

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

149.9

323.0

757

IBZ06

NOMESCO Finland

Evaluation concerning developmental neuropsychiatry

95.8

323.0

399

N06BA04

ATC

methylphenidate; oral

206.6

323.0

2599

364

N06AX12

ATC

bupropion; oral

9.9

323.0

1179

1620

N06BA12

ATC

lisdexamfetamine; oral

165.9

323.0

497

F90.0

ICD-10 Finland

Disturbance of activity and attention

10535.2

323.0

3896

468

N05AH04

ATC

quetiapine; oral

6.2

323.0

1668

4144

F32.9

ICD-10 Finland

Depressive episode, unspecified

4.8

319.0

1311

3718

N06AX16

ATC

venlafaxine; oral

5.0

304.6

1159

3007

N06AX11

ATC

mirtazapine; oral

3.9

299.1

1628

5949

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

4.6

284.3

1194

3397

N06AB10

ATC

escitalopram; oral

3.8

280.3

1544

5627

N05BA04

ATC

oxazepam; oral

4.0

264.6

1340

4494

N06BA09

ATC

atomoxetine; oral

194.0

263.3

273

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

6.6

261.4

746

1344

F90.9

ICD-10 Finland

Hyperkinetic disorder, unspecified

97.6

256.3

283

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

8.5

254.8

600

812

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

4.6

234.4

942

2498

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

8.3

227.4

540

734

N06AB03

ATC

fluoxetine; oral

5.0

224.7

818

1947

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

11.0

217.2

435

436

F93.89

ICD-10 Finland

Other childhood emotional disorders

130.3

208.0

223

N06AB04

ATC

citalopram; systemic

3.8

207.9

1055

3425

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

6.8

206.5

562

930

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

10.5

200.2

411

430

N06AB06

ATC

sertraline; oral

4.2

197.7

883

2546

N03AX09

ATC

lamotrigine; oral

5.9

193.5

589

1124

IGY02

NOMESCO Finland

Psychiatric monitoring contact

8.0

191.0

460

632

F98.8

ICD-10 Finland

Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence

161.6

190.9

201

N05AX08

ATC

risperidone; systemic

6.1

187.0

558

1036

N06AX26

ATC

vortioxetine; oral

5.2

184.4

631

1379

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

3.7

183.4

952

3107

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

6.3

181.0

525

938

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

10.1

179.5

374

400

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

4.8

178.6

666

1594

F84.5

ICD-10 Finland

Asperger syndrome

20.3

175.3

269

141

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

10.0

174.0

366

398

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

6.5

173.5

488

835

P81

ICPC

Hyperkinetic disorder

24.1

173.1

251

110

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

10.8

170.4

343

C07AA05

ATC

propranolol; systemic

3.2

166.2

1102

4289

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

8.3

164.3

386

506

P29

ICPC

Psychological sympt/compl other

4.1

160.6

707

1975

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

8.3

154.9

362

469

N05CF01

ATC

zopiclone; oral

3.2

154.8

983

3683

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

8.0

152.7

367

497

N06AX21

ATC

duloxetine; oral

4.4

152.4

618

1592

F41.1

ICD-10 Finland

Generalized anxiety disorder

4.3

146.1

607

1596

N05AH03

ATC

olanzapine; systemic

4.6

144.6

548

1315

IGY99

NOMESCO Finland

Other psychiatric treatment contact

7.4

141.3

355

513

N05AX12

ATC

aripiprazole; systemic

5.1

139.5

480

1037

N05BA01

ATC

diazepam; systemic, rectal

4.1

136.3

600

1657

P01

ICPC

Feeling anxious/nervous/tense

2.7

135.4

1160

5209

P03

ICPC

Feeling depressed

2.9

128.6

933

3762

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

6.9

124.7

330

512

N03AG01

ATC

valproic acid; systemic, rectal

4.6

120.1

450

1057

N03AX16

ATC

pregabalin; oral

3.1

118.8

752

2747

F31.8

ICD-10 Finland

Other bipolar affective disorders

8.0

118.7

282

372

F61.0

ICD-10 Finland

Mixed personality disorders

9.5

118.3

254

283

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

9.1

112.7

247

285

T36

ICD-10 Finland

Poisoning by systemic antibiotics

4.7

111.2

409

940

SPAT1240

SPAT

Therapeutic discussion

2.7

110.9

937

4098

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

8.6

109.6

249

305

N06BA02

ATC

dexamfetamine; oral

190.6

107.6

112

N05BA12

ATC

alprazolam; oral

4.1

105.3

447

1179

F92.0

ICD-10 Finland

Depressive conduct disorder

527.9

104.9

104

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

5.3

103.6

341

693

P76

ICPC

Depressive disorder

3.3

102.4

579

1934

F40.1

ICD-10 Finland

Social phobias

4.8

98.9

351

774

SPAT1307

SPAT

Psychosocial counselling and guidance

2.7

98.3

767

3171

N05CF02

ATC

zolpidem; oral

2.9

97.7

693

2699

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

3.6

97.7

480

1433

F39

ICD-10 Finland

Unspecified mood [affective] disorder

6.3

95.8

268

445

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

4.3

94.8

382

956

F34.1

ICD-10 Finland

Dysthymia

5.2

94.6

312

634

F99

ICD-10 Finland

Mental disorder, not otherwise specified

6.6

93.3

252

399

P99

ICPC

Psychological disorders other

5.3

92.1

301

605

R03AC02

ATC

salbutamol; inhalant

2.0

91.1

2154

14810

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

6.6

91.0

246

390

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

4.8

91.0

327

729

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

10.0

90.6

187

193

F90.1

ICD-10 Finland

Hyperkinetic conduct disorder

891.8

89.9

F92.9

ICD-10 Finland

Mixed disorder of conduct and emotions, unspecified

307.0

88.9

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

6.4

87.4

243

400

F51.0

ICD-10 Finland

Nonorganic insomnia

2.6

86.5

744

3230

Z71.8

ICD-10 Finland

Other specified counselling

2.1

83.9

1230

6914

R53

ICD-10 Finland

Malaise and fatigue

2.4

83.9

853

4044

P74

ICPC

Anxiety disorder/anxiety state

3.5

83.2

430

1329

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

11.2

82.3

160

147

F43.1

ICD-10 Finland

Post-traumatic stress disorder

4.6

81.4

299

680

F60.9

ICD-10 Finland

Personality disorder, unspecified

8.5

80.9

184

225

N06AB05

ATC

paroxetine; oral

4.1

80.2

339

883

N03AE01

ATC

clonazepam; systemic

5.1

79.9

266

544

XA800

NOMESCO Finland

Neuropsychological investigation

4.6

79.9

299

693

F29

ICD-10 Finland

Unspecified nonorganic psychosis

3.8

79.2

359

995

N02AX02

ATC

tramadol; systemic, rectal

2.1

78.2

1093

5982

A02BC02

ATC

pantoprazole; systemic

1.9

78.1

1781

11813

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

77.9

1567

9922

M54.5

ICD-10 Finland

Low back pain

2.0

77.1

1260

7355

WX110

NOMESCO Finland

Local anesthesy

2.0

76.2

2972

23795

L03

ICPC

Low back symptom/complaint

2.1

75.8

1040

5635

G47.3

ICD-10 Finland

Sleep apnoea

2.7

75.7

578

2324

M79.6

ICD-10 Finland

Pain in limb

2.0

75.7

1212

7003

F81.3

ICD-10 Finland

Mixed disorder of scholastic skills

13.7

74.2

131

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

3.8

73.4

339

953

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

7.8

73.3

175

231

N03AX12

ATC

gabapentin; oral

3.0

73.0

472

1707

F32.1

ICD-10 Finland

Moderate depressive episode

3.0

72.9

469

1692

N05BE01

ATC

buspirone; oral

6.6

71.9

194

306

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

4.3

71.3

285

703

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

6.3

70.1

196

324

P06

ICPC

Sleep disturbance

2.7

69.5

546

2227

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

6.6

69.2

186

292

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

6.0

68.9

198

339

IGP01

NOMESCO Finland

Psychiatric family contact

8.2

68.9

159

199

F92.8

ICD-10 Finland

Other mixed disorders of conduct and emotions

+∞

68.7

N06AX22

ATC

agomelatine; oral

5.4

68.2

217

421

N05AN01

ATC

lithium; oral

5.9

68.1

199

348

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.8

67.7

493

1920

N07BB01

ATC

disulfiram; oral

4.6

67.6

247

557

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

7.9

67.5

160

209

N06AX05

ATC

trazodone; oral

6.2

66.9

188

313

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.1

66.3

882

4672

F98.9

ICD-10 Finland

Unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence

69.8

66.2

N02BE01

ATC

paracetamol; systemic, rectal

1.9

65.5

2853

22942

IGV01

NOMESCO Finland

Psychiatric network contact

8.5

65.2

147

177

R51.80

ICD-10 Finland

Headache

2.2

64.5

815

4214

F81.0

ICD-10 Finland

Specific reading disorder

11.0

63.6

124

115

SAA01

NOMESCO Finland

Simple examination of mouth

1.9

62.7

3062

25365

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.7

62.5

295

842

B18.2

ICD-10 Finland

Chronic viral hepatitis C

7.4

61.8

152

210

F90

ICD-10 Finland

Hyperkinetic disorders

39.5

61.6

F93.9

ICD-10 Finland

Childhood emotional disorder, unspecified

+∞

61.4

L17

ICPC

Foot/toe symptom/complaint

2.0

60.7

932

5214

N05AA02

ATC

levomepromazine; systemic

5.0

60.6

203

417

K02.1

ICD-10 Finland

Caries of dentine

1.8

60.3

2638

20891

F81.9

ICD-10 Finland

Developmental disorder of scholastic skills, unspecified

12.3

59.6

110

F32

ICD-10 Finland

Depressive episode

2.9

59.5

388

1402

SPAT1243

SPAT

Psychiatric/psychological examination

3.3

59.0

327

1056

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.7

58.9

2009

14690

J45.9

ICD-10 Finland

Asthma, unspecified

2.2

58.1

651

3174

N05AF03

ATC

chlorprothixene; systemic

5.7

56.7

170

307

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

4.6

56.6

208

471

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.7

56.5

2092

15594

F41.8

ICD-10 Finland

Other specified anxiety disorders

3.6

56.1

266

761

N01

ICPC

Headache

2.0

55.8

902

5120

R05

ICPC

Cough

1.9

55.4

970

5673

SPAT1389

SPAT

Visit based on need for special support

2.8

55.3

393

1498

IEV99

NOMESCO Finland

Other psychiatric network intervention

10.1

55.0

112

113

R74

ICPC

Upper respiratory infection acute

1.7

54.8

1716

12133

L02

ICPC

Back symptom/complaint

2.5

54.6

495

2165

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

7.9

54.5

128

165

WX290

NOMESCO Finland

Other blockade of nerve

1.7

53.7

2237

17139

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

7.2

53.6

134

190

A04

ICPC

Weakness/tiredness general

2.2

53.3

644

3238

M03BC01

ATC

orphenadrine (citrate); systemic

2.0

52.9

841

4732

R06.0

ICD-10 Finland

Dyspnoea

2.1

52.7

662

3381

P19

ICPC

Drug abuse

6.3

52.6

146

239

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

5.7

52.2

157

285

L01

ICPC

Neck symptom/complaint

2.2

51.6

594

2917

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

8.8

50.6

111

128

S18

ICPC

Laceration/cut

1.8

50.2

1179

7576

N06AA12

ATC

doxepin; systemic

5.6

49.7

150

273

T74.1

ICD-10 Finland

Physical abuse

4.2

49.6

197

481

G44.2

ICD-10 Finland

Tension-type headache

2.2

49.6

574

2821

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.6

49.2

378

1507

Z01.8

ICD-10 Finland

Other specified special examinations

2.0

49.1

706

3806

R02

ICPC

Shortness of breath/dyspnoea

2.5

48.9

431

1854

F90.8

ICD-10 Finland

Other hyperkinetic disorders

79.2

48.8

F91.9

ICD-10 Finland

Conduct disorder, unspecified

170.9

48.8

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

48.1

1262

8368

SPAT1283

SPAT

Restricted health certificate

1.7

48.0

1358

9211

M25.5

ICD-10 Finland

Pain in joint

1.8

47.8

965

5885

F82

ICD-10 Finland

Specific developmental disorder of motor function

7.5

47.7

116

158

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

47.7

1350

9153

F83

ICD-10 Finland

Mixed specific developmental disorders

5.7

47.6

141

251

F95.2

ICD-10 Finland

Combined vocal and multiple motor tic disorder [de la Tourette]

469.8

47.3

L12

ICPC

Hand/finger symptom/complaint

2.0

46.9

671

3601

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.1

46.8

642

3390

N04BC05

ATC

pramipexole; oral

4.7

46.7

167

368

N06AG02

ATC

moclobemide; oral

5.1

46.6

152

303

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

4.0

45.8

191

488

Z07

ICPC

Education problem

5.2

45.8

147

288

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

3.0

45.7

282

977

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.4

45.7

236

721

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

45.5

1775

13104

F33

ICD-10 Finland

Recurrent depressive disorder

4.2

45.4

182

449

N06AX03

ATC

mianserin; oral

4.8

44.7

154

326

R21

ICPC

Throat symptom/complaint

1.7

44.7

1388

9616

M79.7

ICD-10 Finland

Fibromyalgia

4.3

44.6

172

409

M54.4

ICD-10 Finland

Lumbago with sciatica

2.2

44.5

513

2508

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.6

44.4

2289

18117

J01DB01

ATC

cefalexin; oral

1.7

44.4

3069

26307

C07AB07

ATC

bisoprolol; oral

2.0

44.3

677

3722

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

7.8

44.2

104

135

D01

ICPC

Abdominal pain/cramps general

2.0

43.9

632

3393

IBA03

NOMESCO Finland

Psychotherapy evaluation

5.8

43.7

128

225

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.0

43.7

663

3632

M03BX02

ATC

tizanidine; oral

1.6

43.4

1894

14330

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.6

43.2

2268

17976

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

42.8

1028

6585

N05CD07

ATC

temazepam; oral

3.9

42.7

183

479

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

42.2

1613

11761

-1

NOMESCO Finland

1.6

41.9

1771

13242

Z72.2

ICD-10 Finland

Drug use

7.6

41.8

100

133

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.9

41.8

276

1000

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

5.5

41.6

127

235

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

10.5

41.4

R5599

NOMESCO Finland

Other rehabilitation service

4.9

41.4

140

291

M01AE02

ATC

naproxen; oral, rectal

1.6

41.3

2212

17524

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

8.7

40.6

103

Z00.0

ICD-10 Finland

General medical examination

1.8

40.5

757

4457

F31

ICD-10 Finland

Bipolar affective disorder

5.9

40.3

116

200

A01

ICPC

Pain general/multiple sites

2.8

40.3

283

1066

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

40.1

654

3671

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.8

39.8

178

484

N05AB03

ATC

perphenazine; systemic, rectal

4.2

39.2

157

387

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

5.5

39.0

119

220

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.8

38.7

852

5287

X59

ICD-10 Finland

Exposure to unspecified factor

1.9

38.6

703

4097

D11

ICPC

Diarrhoea

1.9

38.4

631

3547

L28

ICPC

Limited function/disability (L)

2.6

38.1

299

1202

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.9

37.8

663

3813

SGA01

NOMESCO Finland

Tooth opening as first aid

1.8

37.6

700

4104

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.8

37.6

721

4272

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.6

37.5

302

1231

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

2.0

37.5

553

2982

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

37.1

537

2873

P01AB01

ATC

metronidazole; oral, rectal

1.6

37.0

1159

7948

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

36.9

2318

18829

F10.20

ICD-10 Finland

Alcohol dependence currently independent

5.8

36.8

107

187

F41.00

ICD-10 Finland

Moderate panic disorder

3.9

36.6

155

402

SPAT1310

SPAT

Counselling related to known health issue

1.6

36.6

1290

9119

R06AE07

ATC

cetirizine; oral

1.5

36.5

1760

13425

IAB03

NOMESCO Finland

Neuropsychiatric consultation

49.0

36.5

SPAT1234

SPAT

Support of social functional capacity

3.9

36.4

158

419

3140B

ICD-9 Finland

Hyperkinetic syndrome of childhood, Attention deficit disorder

+∞

36.4

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

36.4

565

3103

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

36.1

952

6216

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.0

35.7

538

2921

F84.9

ICD-10 Finland

Pervasive developmental disorder, unspecified

13.2

35.7

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

2.4

35.6

332

1460

WX002

NOMESCO Finland

Sedation and analgesia

2.1

35.5

466

2397

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

3.0

35.3

211

716

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

35.2

1230

8656

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.5

34.8

287

1182

P15

ICPC

Chronic alcohol abuse

4.1

34.8

142

357

F81.8

ICD-10 Finland

Other developmental disorders of scholastic skills

9.3

34.7

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

34.6

784

4887

R5140

NOMESCO Finland

Monitoring the use of the aid

2.8

34.5

237

879

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.9

34.4

215

752

A03

ICPC

Fever

1.6

34.3

994

6649

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

2.7

34.1

249

958

P23

ICPC

Adolescent behaviour sympt/compl

6.7

34.0

132

G43.9

ICD-10 Finland

Migraine, unspecified

2.2

34.0

378

1805

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

8.2

33.9

F60.5

ICD-10 Finland

Anankastic personality disorder

5.8

33.7

172

IEP99

NOMESCO Finland

Other psychiatric family intervention

7.7

33.6

103

SPAT1301

SPAT

No procedures

1.6

33.6

1123

7792

SPAT1215

SPAT

Assessment of need for medical rehabilitation

3.0

33.6

201

683

N06AB08

ATC

fluvoxamine; oral

5.6

33.3

100

182

N06AA09

ATC

amitriptyline; systemic

3.2

33.3

185

597

AA1AD

NOMESCO Finland

CT of head and brain

2.0

33.2

443

2288

ICC01

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric outpatient clinic

6.2

33.2

148

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.7

33.2

237

901

SPAT1254

SPAT

Administration of medicine

1.8

33.1

639

3776

F33.8

ICD-10 Finland

Other recurrent depressive disorders

6.4

33.1

141

L15

ICPC

Knee symptom/complaint

1.8

33.1

665

3984

N06BA07

ATC

modafinil; oral

11.6

33.1

F60.8

ICD-10 Finland

Other specific personality disorders

7.5

33.0

106

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

7.3

32.9

110

SPAT1260

SPAT

Consultation of another employee

1.8

32.9

620

3636

SPAT1241

SPAT

Extensive assessment of psychosocial situation

3.8

32.6

143

383

E66.8

ICD-10 Finland

Other obesity

2.8

32.4

220

809

EBA00

NOMESCO Finland

Extraction of tooth

1.5

32.3

1431

10607

IEY01

NOMESCO Finland

Psychoeducation, individual

5.4

32.2

186

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.8

32.1

630

3742

A05

ICPC

Feeling ill

1.9

32.0

536

3019

S06.0

ICD-10 Finland

Concussion

2.0

31.9

467

2501

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.4

31.8

161

485

R05

ICD-10 Finland

Cough

1.8

31.7

615

3638

M79.1

ICD-10 Finland

Myalgia

1.9

31.6

485

2644

N06AA06

ATC

trimipramine; systemic

5.5

31.5

178

R52.9

ICD-10 Finland

Pain, unspecified

2.4

31.4

286

1243

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.1

31.3

364

1774

SPAT1272

SPAT

Drug screening

8.0

31.3

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.0

31.2

452

2408

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

4.5

31.1

114

259

A02BC05

ATC

esomeprazole; systemic

1.6

31.0

937

6308

S29

ICPC

Skin symptom/complaint other

1.8

30.9

565

3273

R11

ICD-10 Finland

Nausea and vomiting

2.2

30.8

342

1630

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.6

30.8

1130

7986

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

30.8

933

6284

D10

ICPC

Vomiting

1.9

30.8

462

2496

A06AC01

ATC

ispaghula (psylla seeds); oral

1.9

30.8

490

2706

M54.2

ICD-10 Finland

Cervicalgia

2.5

30.7

246

997

R03BA02

ATC

budesonide; inhalant

1.8

30.5

626

3765

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

1.9

30.5

484

2670

L08

ICPC

Shoulder symptom/complaint

1.9

30.4

455

2455

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

30.4

1274

9291

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.2

30.3

320

1495

SPAT1216

SPAT

Assessment of functional ability

2.3

30.2

300

1360

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

30.2

2978

26102

M01AB05

ATC

diclofenac; systemic, rectal

1.5

30.1

1808

14251

R42

ICD-10 Finland

Dizziness and giddiness

1.9

30.1

470

2577

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

5.7

29.9

153

F84.8

ICD-10 Finland

Other pervasive developmental disorders

18.5

29.9

SPAT1312

SPAT

General health counselling

1.5

29.8

1485

11242

F91.2

ICD-10 Finland

Socialized conduct disorder

302.3

29.7

H03AA01

ATC

levothyroxine sodium; systemic

1.8

29.7

575

3392

A29

ICPC

General symptom/complaint other

2.2

29.7

337

1625

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

8.3

29.5

P24

ICPC

Specific learning problem

4.8

29.4

101

215

F41.3

ICD-10 Finland

Other mixed anxiety disorders

3.6

29.4

136

382

F50.9

ICD-10 Finland

Eating disorder, unspecified

3.7

29.2

130

353

R4110

NOMESCO Finland

Physiotherapy

1.7

29.2

699

4403

M03BC51

ATC

orphenadrine, combinations; systemic

1.7

29.0

782

5094

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

4.9

28.9

201

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.4

28.9

256

1097

F98.00

ICD-10 Finland

Nonorganic enuresis nocturna

15.7

28.8

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

28.6

1176

8509

R4140

NOMESCO Finland

Psychotherapy

6.5

28.5

116

N03AX11

ATC

topiramate; oral

3.2

28.1

153

487

F91.3

ICD-10 Finland

Oppositional defiant disorder

+∞

28.1

A02BC03

ATC

lansoprazole; oral

1.8

28.1

529

3092

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.6

28.0

818

5437

R20.2

ICD-10 Finland

Paraesthesia of skin

2.3

28.0

262

1154

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.0

27.9

371

1911

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.0

27.9

395

2085

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.0

27.9

367

1883

F32.8

ICD-10 Finland

Other depressive episodes

3.9

27.7

118

309

IBB03

NOMESCO Finland

Assessment of vocational rehabilitation needs in a mental health context

7.9

27.7

E66.01

ICD-10 Finland

Obesity due to excess calories

2.1

27.6

331

1633

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

3.3

27.6

144

445

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

27.4

767

5038

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

4.7

27.3

205

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

8.3

27.3

R00.2

ICD-10 Finland

Palpitations

2.3

27.3

275

1255

L86

ICPC

Back syndrome with radiating pain

2.9

27.3

168

582

Z00.8

ICD-10 Finland

Other general examinations

2.1

27.2

328

1622

KMAK

NOMESCO Finland

1.4

26.9

1969

16007

N17

ICPC

Vertigo/dizziness

2.1

26.9

319

1564

TLC00

NOMESCO Finland

Insertion of intrauterine device

2.2

26.8

300

1436

IAZ98

NOMESCO Finland

Other internal psychiatric consultation

13.1

26.7

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.3

26.7

268

1220

R06AX27

ATC

desloratadine; oral

1.5

26.5

1210

8925

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

5.5

26.5

148

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

3.1

26.4

152

503

SPAT1396

SPAT

Meeting with multidisciplinary group of experts

4.4

26.4

226

R07.4

ICD-10 Finland

Chest pain, unspecified

1.8

26.3

517

3057

Z06

ICPC

Unemployment problem

6.7

26.2

100

R52.2

ICD-10 Finland

Other chronic pain

3.5

26.2

127

371

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.3

26.1

247

1093

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

26.1

815

5498

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

26.1

747

4926

K04.08

ICD-10 Finland

Other specified pulpit

2.0

26.1

337

1713

T82

ICPC

Obesity

2.9

26.0

165

581

N05BA02

ATC

chlordiazepoxide; systemic

5.9

25.9

124

Z02.7

ICD-10 Finland

Issue of medical certificate

2.3

25.9

240

1052

SPAT1058

SPAT

PEF monitoring instruction

2.3

25.9

260

1184

X78

ICD-10 Finland

Intentional self-harm by sharp object

5.6

25.9

136

N76.0

ICD-10 Finland

Acute vaginitis

2.0

25.8

375

1997

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

4.0

25.6

106

271

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

25.6

597

3717

R07

ICPC

Sneezing/nasal congestion

1.9

25.5

420

2339

F10.25

ICD-10 Finland

Alcohol dependence continuous use

5.6

25.4

135

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.5

25.3

206

842

K04.0

ICD-10 Finland

Pulpitis

1.8

25.3

469

2718

G47.9

ICD-10 Finland

Sleep disorder, unspecified

3.7

25.3

112

304

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

5.8

25.3

124

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

25.2

647

4140

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

7.6

25.1

F88

ICD-10 Finland

Other disorders of psychological development

14.5

25.0

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

4.6

25.0

193

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

3.7

24.9

111

303

Z29

ICPC

Social problem NOS

3.2

24.9

132

413

R01AD09

ATC

mometasone; nasal

1.4

24.8

1615

12761

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

24.8

1004

7188

M01AH05

ATC

etoricoxib; oral

1.4

24.8

1526

11926

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

2.1

24.6

301

1496

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

5.0

24.6

161

F91.1

ICD-10 Finland

Unsocialized conduct disorder

249.8

24.6

F41

ICD-10 Finland

Other anxiety disorders

3.5

24.5

118

343

IER01

NOMESCO Finland

Psychoeducation, group

5.2

24.4

150

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.8

24.3

164

602

R96

ICPC

Asthma

2.1

24.1

274

1318

F50.2

ICD-10 Finland

Bulimia nervosa

4.7

24.1

178

A02BC01

ATC

omeprazole; systemic

1.6

24.1

630

4046

IEY03

NOMESCO Finland

Vocational rehabilitation

9.0

24.1

H01

ICPC

Ear pain/earache

1.7

24.1

569

3555

SPAT1395

SPAT

Health check-up of persons outside student and working life

3.8

24.0

105

282

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

5.2

24.0

145

A97

ICPC

No disease

1.6

23.9

645

4175

P22

ICPC

Child behaviour symptom/complaint

4.1

23.9

239

R03BA05

ATC

fluticasone; inhalant

1.6

23.9

686

4516

F93.80

ICD-10 Finland

Generalized anxiety in the bardom age

+∞

23.9

L16

ICPC

Ankle symptom/complaint

1.8

23.7

445

2586

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.8

23.6

410

2324

E0000UV

ATC

1.4

23.6

1461

11395

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

4.8

23.6

169

N06AX17

ATC

milnacipran; oral

6.6

23.6

RT420

NOMESCO Finland

15.9

23.5

J02AC01

ATC

fluconazole; systemic

1.5

23.5

1211

9112

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

2.7

23.4

167

633

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.8

23.4

157

576

Z72.0

ICD-10 Finland

Tobacco use

3.6

23.4

107

299

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

23.4

1793

14554

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.9

23.3

355

1922

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.1

23.1

268

1302

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

9.6

23.1

Z01.7

ICD-10 Finland

Laboratory examination

1.9

22.9

367

2020

K08.3

ICD-10 Finland

Retained dental root

2.7

22.9

158

590

P27

ICPC

Fear of mental disorder

3.7

22.9

102

279

IEP01

NOMESCO Finland

Psychoeducation, family

10.3

22.9

Z25

ICPC

Assault/harmful event problem

4.3

22.7

203

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.9

22.7

378

2112

IER03

NOMESCO Finland

Psychiatric disorder-specific group intervention

7.6

22.6

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

5.9

22.6

110

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

22.6

550

3458

R4120

NOMESCO Finland

Occupational therapy

2.4

22.5

192

807

I10

ICD-10 Finland

Essential (primary) hypertension

1.7

22.4

536

3352

Z86.4

ICD-10 Finland

Personal history of psychoactive substance abuse

6.7

22.4

F80.2

ICD-10 Finland

Receptive language disorder

4.9

22.3

153

N06AX18

ATC

reboxetine; oral

6.9

22.3

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3009508) Creatinine [Moles/volume] in Urine

1958

7446

3.72

307.65

4.2

3.6

mmol/l

8.7

8.9

0.59

1718

6639

(1001926) Buprenorphine [Presence] in Urine by Screen method

1634

3567

6.38

307.65

3.4

2.1

—

(3027944) Amphetamines [Presence] in Urine

1705

4642

5.10

307.65

3.4

2.0

—

(3011288) Drugs identified in Urine by Screen method

1681

3080

7.80

307.65

4.8

2.7

—

(3016879) Cocaine [Presence] in Urine

1737

4305

5.71

307.65

3.4

2.0

—

(3028707) Methadone [Presence] in Urine by Screen method

1403

1705

11.12

307.65

3.5

2.8

—

(3000764) Benzodiazepines [Presence] in Urine

1766

4660

5.37

307.65

3.4

2.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

494

532

10.12

307.65

2.0

2.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2157

6272

5.40

307.65

2.2

1.7

1.5

1.3

13.61

1957

5730

(3028300) Cannabinoids [Presence] in Urine

1775

4708

5.35

307.65

3.5

2.0

—

(3027008) Opiates [Presence] in Urine

1768

4701

5.33

307.65

3.4

1.9

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4081

28564

3.98

254.63

4.7

3.7

pmol/l

14.3

14.4

0.25

3842

26328

(3044889) 12 lead EKG panel

2959

17820

2.71

231.66

2.8

2.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1834

8795

2.73

227.30

1.8

1.6

pmol/l

99.0

98.7

0.09

1049

4986

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3389

22085

2.81

222.38

6.1

u/l

76.6

76.0

0.35

3197

20814

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2112

10955

2.63

222.14

3.5

3.2

u/l

30.8

30.0

0.22

2002

10435

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4351

32884

4.81

218.03

5.6

4.2

mu/l

1.7

1.8

1.77

4188

31223

(44816559) Phosphatidylethanol [Mass/volume] in Blood

474

986

5.16

212.41

1.5

1.3

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1676

7909

2.69

211.57

2.2

2.7

mmol/l

2.3

2.4

0.98

1515

7197

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2203

11896

2.55

209.82

6.2

6.3

mmol/l

1.2

2.10

1917

10193

(3019550) Sodium [Moles/volume] in Serum or Plasma

4335

33294

4.41

197.67

11.5

8.3

mmol/l

139.6

139.5

2.59

4233

32186

(3023103) Potassium [Moles/volume] in Serum or Plasma

4340

33368

4.43

197.37

11.6

8.4

mmol/l

3.9

7.12

4221

32144

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2007

10750

2.46

189.54

5.9

6.2

mmol/l

1.2

4.03

1851

9905

(3019150) Specific gravity of Urine by Refractometry

1575

7539

2.59

189.35

3.4

2.9

kg/l

1.0

1.75

124

1122

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3627

25919

2.63

172.14

4.1

2.8

u/l

33.1

32.7

0.22

3487

24918

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3954

29626

2.93

168.13

3.7

2.7

mmol/l

5.6

5.5

2.72

3707

27808

(3021960) Folate [Moles/volume] in Serum or Plasma

1098

4706

2.70

161.86

1.5

1.4

nmol/l

18.9

19.9

1.74

991

4267

(3019309) Folate [Moles/volume] in Red Blood Cells

812

2994

3.02

158.52

1.7

1.6

nmol/l

1046.8

1149.8

2.68

654

2329

(4198724)

268

432

6.43

156.82

2.6

3.0

—

(3018418) pH of Serum or Plasma

1316

6548

2.36

138.26

3.0

3.7

7.4

1.24

241

1261

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2124

12948

2.12

133.97

2.6

2.4

nmol/l

68.3

69.6

1.44

1981

12249

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2155

13496

2.06

123.40

5.0

5.2

umol/l

10.2

10.8

1.50

1985

12572

(3024561) Albumin [Mass/volume] in Serum or Plasma

1775

10397

2.10

121.39

4.3

5.2

g/l

38.2

37.8

2.18

1618

9725

(3042517) Benzodiazepines panel - Urine

119

12.39

119.02

3.0

2.9

—

(3013707) Erythrocyte sedimentation rate by Westergren method

3249

23929

2.09

115.00

3.8

3.5

mm/h

7.6

7.5

0.10

3031

22440

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1205

6207

2.23

113.37

2.3

2.1

u/l

188.2

263.7

1.65

1152

5911

(3013826) Glucose [Moles/volume] in Serum or Plasma

2512

16966

1.98

112.67

4.6

4.4

mmol/l

6.0

6.2

2.61

2331

15012

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1385

7558

2.14

112.49

2.2

2.3

mg/l

2.5

2.6

0.77

1169

6563

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4475

38085

3.95

112.17

9.7

7.3

u/l

28.5

27.2

3.03

4370

36948

(3015736) pH of Urine

2093

13359

1.98

109.70

3.5

2.7

—

6.0

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2847

20184

1.98

109.68

7.7

8.5

e9/l

3.9

0.16

2457

17695

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

946

4492

2.35

107.39

1.6

1.5

pmol/l

29397718.8

30129113.3

0.01

813

3963

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3834

30480

2.27

105.67

9.2

7.0

ml/min/173m2

104.1

102.1

7.95

3021

23696

(3013115) Eosinophils [#/volume] in Blood

2638

18521

1.92

101.06

6.0

6.8

e9/l

0.2

0.58

2314

16576

(3006315) Basophils [#/volume] in Blood

2564

17879

1.91

99.81

5.6

6.4

e9/l

0.0

1.36

2201

15729

(3001604) Monocytes [#/volume] in Blood

2556

17834

1.90

99.00

5.6

6.4

e9/l

0.5

0.10

2201

15725

(3036481) Cortisol [Moles/volume] in Serum or Plasma

762

3417

2.43

97.67

2.0

2.1

nmol/l

364.0

378.0

1.24

707

3171

(42870588) Differential panel, method unspecified - Blood

1837

11556

1.93

97.27

5.4

6.6

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1466

8541

2.01

97.17

2.7

2.5

u/l

54.1

55.9

0.71

1330

7934

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2728

19532

1.89

96.52

3.4

2.9

ug/l

65.5

68.6

0.74

2572

18571

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1830

11544

1.92

95.70

1.5

1.4

u/ml

2.0

1.8

0.11

424

3080

(3013512) EKG study

1018

5281

2.15

91.63

2.6

2.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3363

26049

1.95

90.42

4.0

3.4

mmol/mol

36.3

36.6

0.66

3137

24822

(3022096) Basophils/100 leukocytes in Blood

2354

16309

1.84

89.98

5.7

6.6

0.7

0.61

2191

15387

(3019069) Monocytes/100 leukocytes in Blood

2435

17058

1.84

89.69

5.8

6.6

7.9

8.1

1.62

2281

16183

(3006504) Eosinophils/100 leukocytes in Blood

2421

16931

1.84

89.65

5.6

6.4

2.8

0.08

2252

15957

(3019198) Lymphocytes [#/volume] in Blood

2621

18798

1.84

89.27

5.7

6.3

e9/l

2.1

2.0

2.35

2306

16938

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

732

3371

2.35

87.69

1.9

2.4

mmol/l

2.4

1.02

618

2903

(3021589) Normoblasts [#/volume] in Blood

2319

16258

1.80

82.75

7.9

8.0

e9/l

0.0

1.11

1870

13269

(3007164) IgA [Mass/volume] in Serum or Plasma

1592

9971

1.87

82.15

1.5

1.4

g/l

2.0

0.47

897

6347

(3018010) Neutrophils/100 leukocytes in Blood

2482

17814

1.79

81.22

5.5

6.1

54.3

54.9

1.93

2320

16928

(3002030) Lymphocytes/100 leukocytes in Blood

2504

18075

1.78

79.80

5.6

6.3

31.4

31.2

0.68

2339

17129

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1009

5563

2.00

75.34

1.3

iu/ml

23.0

19.2

0.28

229

1559

(3009466) Valproate [Moles/volume] in Serum or Plasma

208

560

3.79

65.68

4.4

5.9

umol/l

360.0

389.9

1.91

185

494

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

927

5192

1.95

65.07

1.3

u/ml

4.7

8.3

1.71

353

2197

(3004789) Transferrin [Mass/volume] in Serum or Plasma

727

3736

2.09

64.98

2.4

2.3

g/l

2.5

0.91

659

3485

(3002582) Erythrocytes [#/volume] in Urine

1374

8737

1.78

64.21

3.2

2.9

e6/l

73.6

86.1

0.15

1027

6495

(40758558) Short blood count panel - Blood

1325

8379

1.78

62.87

5.6

6.9

—

(3022948) Iron [Moles/volume] in Serum or Plasma

778

4163

2.01

62.02

2.4

2.3

umol/l

15.1

15.0

0.14

728

3897

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3759

31608

1.85

61.29

3.6

2.9

mmol/l

2.9

2.8

1.14

3524

30058

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1897

13325

1.68

61.01

2.8

2.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4266

37487

2.25

60.90

11.9

8.9

mg/l

18.8

20.1

2.05

3250

27602

(3017446) Testosterone [Moles/volume] in Serum or Plasma

614

3062

2.13

59.04

2.5

2.1

nmol/l

12.1

11.8

0.40

525

2759

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2021

14533

1.65

58.63

2.9

2.3

—

(3018095) Leukocytes [#/volume] in Urine

1618

11133

1.66

54.83

3.7

3.3

e6/l

63.0

56.2

0.13

1096

7101

(3030467) Casts [#/volume] in Urine by Automated count

1236

7935

1.73

54.24

3.1

2.8

e6/l

0.3

0.2

0.25

898

5793

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

148

358

4.18

54.16

10.0

11.6

mmol/l

0.6

0.13

129

326

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

643

3372

2.02

53.68

2.5

2.4

24.4

24.7

0.18

571

2969

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3721

31589

1.76

53.63

3.5

2.9

mmol/l

4.6

4.7

3.04

3511

30263

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3691

31343

1.74

52.14

3.4

2.8

mmol/l

1.4

28.48

3460

29978

(3003458) Phosphate [Moles/volume] in Serum or Plasma

636

3366

2.00

51.61

6.3

7.3

mmol/l

1.1

1.11

602

3188

(3012095) Magnesium [Moles/volume] in Serum or Plasma

677

3701

1.94

49.90

4.6

4.9

mmol/l

0.8

0.44

627

3496

(36304419) Bacteria [Presence] in Urine

1232

8070

1.69

49.43

3.1

2.7

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1170

7565

1.70

49.26

2.6

2.3

ng/l

12.6

68.7

0.76

455

2693

(3002385) Erythrocyte distribution width [Ratio]

3894

33770

1.78

48.61

14.7

11.1

13.2

1.17

3834

33057

(3000850) Epithelial cells [#/volume] in Urine

963

5933

1.76

48.12

2.6

2.4

e6/l

8.4

7.8

0.44

835

5168

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

529

2697

2.05

47.42

2.3

2.5

u/l

30.2

56.0

0.83

449

2314

(3026782) Osmolality of Urine

911

5573

1.76

46.48

2.8

2.4

mosm/kgh2o

555.5

572.4

1.05

771

4778

(3037522) Nuclear Ab [Titer] in Serum

847

5081

1.79

46.20

1.5

1.4

titre

441.2

544.0

0.82

132

899

(40761511) CBC panel - Blood by Automated count

4387

39710

2.24

46.20

11.0

7.9

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1034

6571

1.71

45.96

1.6

mmol/l

1.6

1.4

4.56

888

5900

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

183

5.21

45.92

3.4

2.9

umol/l

210.6

200.7

0.06

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

496

2512

2.06

45.18

2.8

3.6

pmol/l

4.9

4.7

1.33

439

2292

(3032080) INR in Blood by Coagulation assay

1205

8007

1.65

45.06

4.0

4.5

inr

1.0

1.1

3.07

487

2860

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

686

3926

1.85

43.49

2.7

2.8

ng/l

205.1

648.0

3.45

285

1854

(3031040) Bacteria [#/volume] in Urine by Automated count

2796

22627

1.54

43.40

4.2

3.6

e6/l

164.0

944.0

2.92

249

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

125

316

3.98

43.12

2.0

1.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3522

30068

1.61

42.74

3.1

2.6

mmol/l

1.3

1.2

6.61

3302

28808

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

597

3297

1.90

42.24

3.1

3.4

umol/l

5.7

6.1

0.30

498

2780

(40768797) Stomach Pathology biopsy report

590

3247

1.91

42.18

1.2

—

(3033658) Prothrombin time (PT) actual/Normal

1107

7307

1.65

42.05

4.2

4.1

96.3

94.3

2.26

1075

7100

(3037467) Urinalysis macro (dipstick) panel - Urine

2924

24007

1.53

41.52

4.0

3.6

—

(3007461) Platelets [#/volume] in Blood

4648

43561

4.03

40.09

18.2

13.0

e9/l

270.4

262.1

16.97

4559

42423

(3021387) Prolactin [Units/volume] in Serum or Plasma

597

3363

1.86

39.56

1.6

mu/l

331.4

309.9

0.64

534

3028

(36660697) Celiac disease serology panel - Serum

709

4215

1.78

39.33

1.2

—

(3035941) MCH [Entitic mass]

4650

43628

4.03

39.27

18.1

12.9

29.8

0.08

4618

43108

(3026361) Erythrocytes [#/volume] in Blood

4650

43638

4.02

39.05

18.1

13.0

e12/l

4.7

4.6

5.68

4543

42449

(3024731) MCV [Entitic volume]

4649

43626

3.99

38.97

18.1

12.9

88.8

88.7

0.31

4617

43106

(3019225) pH of Specimen

391

1912

2.11

38.92

3.1

3.2

—

(3010813) Leukocytes [#/volume] in Blood

4650

43661

3.99

38.53

18.2

13.0

e9/l

6.9

6.8

1.89

4548

42450

(3000963) Hemoglobin [Mass/volume] in Blood

4650

43662

3.99

38.51

18.3

13.1

g/l

138.3

137.4

5.60

4618

43139

(3022217) INR in Platelet poor plasma by Coagulation assay

343

1605

2.20

38.19

5.4

8.1

inr

1.1

0.07

316

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

101

242

4.19

37.48

1.8

iu/ml

2041171.1

2092622.0

0.01

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

728

4422

1.74

37.31

2.8

2.6

e6/l

4.5

3.8

0.87

374

2250

(3023368) Bacteria identified in Blood by Culture

888

5728

1.65

36.26

3.9

3.8

—

(3023511) Choriogonadotropin [Units/volume] in Urine

466

2518

1.92

34.92

1.5

1.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

228

950

2.44

33.23

2.1

1.8

pmol/l

189.1

198.3

0.53

219

912

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

457

2494

1.89

33.17

4.1

3.8

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

627

3777

1.74

32.81

1.3

iu/ml

86.9

151.3

5.89

190

1421

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

619

3742

1.73

31.93

1.8

1.7

—

(3048689) Calprotectin [Mass/mass] in Stool

960

6513

1.57

31.28

2.3

2.9

ug/g

99.3

115.8

0.73

678

5201

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1235

8860

1.51

31.12

2.5

2.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

375

1956

1.97

31.09

8.5

mmol/l

1.4

0.16

352

1851

(3017143) Hepatitis C virus Ab [Presence] in Serum

1134

7995

1.53

31.02

1.9

1.7

—

(3026008) Bacteria identified in Urine by Culture

1142

8081

1.52

30.65

2.4

2.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

387

2051

1.94

30.62

5.5

5.0

kpa

5.1

1.01

365

1953

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

332

1675

2.03

30.23

3.1

3.3

mmol/l

1.2

0.19

279

1448

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

715

4557

1.65

30.09

2.6

2.5

e6/l

0.9

1.1

0.34

363

2388

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

418

2286

1.88

30.05

2.9

3.2

g/l

0.2

0.02

381

2151

(3009343) pH of Capillary blood

384

2045

1.93

29.93

5.5

5.0

7.4

0.34

181

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

135

4.88

29.85

1.5

2.3

umol/l

15.0

16.4

0.44

135

(3014576) Chloride [Moles/volume] in Serum or Plasma

431

2389

1.86

29.70

8.0

mmol/l

104.9

105.0

0.10

422

2343

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

376

2012

1.92

28.87

5.6

5.0

mmol/l

1.0

1.1

0.21

250

1433

(3021447) Carbon dioxide [Partial pressure] in Venous blood

458

2620

1.80

28.45

6.3

5.7

kpa

5.9

0.15

440

2542

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1011

7072

1.52

28.32

2.1

mg/l

0.8

0.9

0.91

669

4836

(3002032) Base excess in Venous blood by calculation

452

2599

1.79

27.57

6.4

5.7

mmol/l

1.3

1.6

0.91

365

2102

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1013

7150

1.51

27.03

2.3

2.0

—

(3042936) Bacteria identified in Isolate by Culture

583

3628

1.67

26.73

1.8

1.9

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

303

1566

1.97

25.73

2.0

1.6

nmol/l

37.1

38.8

0.53

292

1552

(3007853) Bacteria identified in Skin by Aerobe culture

608

3871

1.63

25.41

1.8

1.6

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

279

1417

2.00

24.89

1.2

1.3

u/ml

0.3

1.1

1.60

104

(3013139) Helicobacter pylori Ag [Presence] in Stool

371

2082

1.82

24.46

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

398

2291

1.78

24.10

6.1

5.5

kpa

5.1

5.0

0.56

382

2226

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

413

2404

1.76

24.07

1.7

1.6

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

578

3687

1.62

23.89

2.5

3.1

29.5

29.7

0.39

562

3568

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

421

2470

1.75

23.86

2.2

au/ml

23.7

19.6

0.28

222

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

532

3332

1.65

23.65

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

5.88

23.41

1.2

—

(3000991) Gas panel - Venous blood

415

2441

1.74

23.30

10.2

9.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

525

3312

1.63

22.63

2.1

1.8

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

414

2465

1.72

22.23

1.7

1.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1838

14846

1.36

22.21

2.0

1.8

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

170

745

2.30

22.15

1.2

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

462

7041

0.61

22.14

1.4

1.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1198

9031

1.41

21.95

4.0

4.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1031

7574

1.44

21.79

3.0

2.9

—

(3007463) Buprenorphine [Presence] in Urine

6.97

21.66

6.1

5.7

—

(3023183) Ammonium ion [Moles/volume] in Plasma

128

500

2.57

21.46

2.9

3.1

umol/l

33.5

32.4

0.23

107

451

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

163

715

2.29

21.20

2.6

2.5

ug/l

549.1

346.7

0.38

147

629

(3009261) Glucose [Presence] in Urine by Test strip

2098

17384

1.34

21.09

3.2

2.9

estimate

0.0

0.25

477

3533

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

223

1110

2.03

21.05

1.6

1.5

—

(3035350) Ketones [Presence] in Urine by Test strip

2086

17274

1.34

21.04

3.2

2.9

estimate

0.0

1.08

458

3489

(3021440) Promyelocytes/100 leukocytes in Blood

396

2364

1.71

21.03

3.6

4.6

0.1

0.64

534

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

337

1922

1.79

21.01

6.9

6.1

mmol/l

23.9

24.0

0.19

319

1827

(3020191) Ethanol [Moles/volume] in Serum or Plasma

109

397

2.75

20.99

1.6

1.5

promille

1.4

0.15

300

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

498

3158

1.62

20.96

3.2

3.3

ng/l

582.5

495.2

0.18

346

2391

(3023323) Follitropin [Units/volume] in Serum or Plasma

503

3204

1.61

20.78

1.5

iu/l

12.6

15.4

2.03

395

2636

(21494755) Public health laboratory ask at order entry panel

423

6471

0.61

20.42

1.2

1.3

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

153

665

2.31

20.34

3.0

3.1

nmol/l

25.4

23.9

0.68

145

644

(3036180) Methadone [Presence] in Urine

10.90

20.34

1.6

2.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

2081

17293

1.34

20.21

4.3

4.1

estimate

0.0

0.41

481

3647

(3000570) Elastase.pancreatic [Mass/mass] in Stool

148

637

2.33

20.13

1.3

1.4

ug/g

319.1

333.3

0.29

311

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

383

2300

1.70

19.89

1.2

au/ml

29.0

38.8

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

284

1566

1.84

19.78

4.9

5.0

ng/l

66.9

67.7

0.06

254

1469

(3015235) Bicarbonate [Moles/volume] in Capillary blood

135

564

2.40

19.64

3.0

5.0

mmol/l

23.8

23.7

0.12

119

513

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

340

1983

1.75

19.61

1.5

1.6

mg/l

3.2

3.6

0.53

260

1276

(3012501) Base excess in Blood by calculation

136

575

2.37

19.28

3.7

3.5

mmol/l

1.8

0.01

324

(3017181) Myelocytes/100 leukocytes in Blood

400

2451

1.67

19.24

3.6

4.5

0.8

0.04

568

(3029937) Albumin [Presence] in Urine by Test strip

1183

9096

1.38

18.79

3.4

3.1

estimate

0.0

1.74

472

3553

(3010421) pH of Blood

148

657

2.26

18.75

3.6

3.4

7.4

1.17

133

566

(3025159) Blasts/100 leukocytes in Blood

375

2277

1.68

18.66

3.7

4.6

0.0

0.2

0.59

462

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

209

1067

1.98

18.39

1.8

1.5

—

(1616796) Gas panel - Central venous blood

133

570

2.34

18.30

3.3

3.1

—

(3016502) Oxygen saturation in Arterial blood

289

1647

1.78

18.05

9.1

9.8

95.7

96.8

1.40

284

1584

(3000494) Fungus identified in Specimen by Culture

515

3409

1.55

17.95

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

4149

38597

1.50

17.84

13.5

9.7

40.7

0.29

3429

33346

(3027801) Oxygen [Partial pressure] in Arterial blood

321

1893

1.72

17.79

8.4

9.0

kpa

13.3

14.6

3.77

310

1808

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

321

1894

1.72

17.75

8.5

9.0

kpa

5.1

5.0

1.24

311

1806

(3005322) IgE [Units/volume] in Serum or Plasma

491

3223

1.56

17.75

1.4

1.3

u/ml

276.4

293.1

0.11

453

3005

(3003396) Base excess in Arterial blood by calculation

322

1904

1.72

17.67

8.4

9.0

mmol/l

0.7

0.5

0.28

242

1412

(3009214) Lutropin [Units/volume] in Serum or Plasma

413

2609

1.62

17.57

1.5

1.6

u/l

6.7

7.5

0.89

312

2089

(3030981) Hyaline casts [#/volume] in Urine by Automated count

226

1211

1.88

17.24

2.3

2.5

e6/l

0.2

0.12

220

1162

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

256

1429

1.81

17.14

1.6

1.7

—

(3002179) Metamyelocytes/100 leukocytes in Blood

370

2295

1.64

16.94

3.2

4.2

0.4

0.5

0.26

433

(3002173) Hemoglobin [Mass/volume] in Arterial blood

270

1539

1.78

16.86

8.8

9.9

g/l

128.9

125.7

1.84

261

1482

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

364

2255

1.64

16.74

3.0

2.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

354

2179

1.65

16.70

1.5

1.8

g/l

1.3

1.2

0.79

324

2038

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

140

2788

0.48

16.67

1.3

1.5

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

6.61

16.28

1.1

1.2

mg/l

42.0

51.9

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

152

727

2.10

16.03

1.2

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

204

1085

1.89

15.94

1.8

2.1

ug/l

3.9

7.5

4.13

176

941

(3008898) HLA-B27 [Presence]

337

2074

1.65

15.90

1.1

—

(3022145) Colonoscopy Study observation

450

2971

1.55

15.81

1.3

1.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

269

1574

1.73

15.34

6.4

5.0

mmol/l

24.2

24.3

0.30

264

1527

(3050129) First trimester maternal screen panel - Serum or Plasma

303

4702

0.61

15.19

1.3

1.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

433

2868

1.54

14.97

2.3

2.7

g/l

10.1

10.4

0.99

388

2657

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

200

1080

1.86

14.92

1.2

1.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

780

5791

1.39

14.89

2.2

2.4

umol/l

1377.5

2723.4

0.95

666

5303

(1002224) Polysomnography panel

273

1618

1.71

14.86

1.1

—

(3028626) Oxygen [Partial pressure] in Capillary blood

234

1328

1.78

14.85

7.1

5.8

kpa

9.5

9.7

0.71

220

1268

(3014765) Yersinia sp identified in Stool by Organism specific culture

201

1089

1.86

14.84

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

202

1097

1.85

14.81

1.2

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

172

891

1.94

14.57

1.2

2.0

e6/l

251.4

742.2

0.76

138

718

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

172

891

1.94

14.57

1.2

2.0

e6/l

12.5

20.9

0.75

133

683

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

686

5000

1.41

14.56

2.8

2.4

u/l

5441.5

6560.2

0.37

209

2020

(3007566) Smooth muscle Ab [Titer] in Serum

190

1018

1.88

14.53

1.3

1.5

titre

74.2

79.6

0.13

107

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

394

2573

1.56

14.51

3.1

2.5

29.7

31.6

2.69

307

1988

(40767503) Oxygen content in Capillary blood by calculation

108

470

2.30

14.42

2.3

2.2

18.7

17.6

2.03

228

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

177

934

1.90

14.19

11.8

12.2

mmol/l

23.7

24.0

0.67

164

897

(3020779) Urea [Moles/volume] in Serum or Plasma

335

2120

1.60

14.12

10.4

9.3

mmol/l

5.7

6.1

1.21

326

2055

(3022313) Gas panel - Capillary blood

269

1612

1.69

14.06

6.6

5.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

645

4698

1.41

13.69

3.9

4.5

mg/mmol

11.3

12.8

0.27

430

3392

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

236

1378

1.73

13.58

1.7

1.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

2046

17555

1.26

13.56

2.5

2.1

—

(3044290) Cell count panel - Cerebral spinal fluid

163

862

1.90

13.01

1.2

2.0

—

(3027945) Reticulocytes/100 erythrocytes in Blood

362

2379

1.54

12.95

3.2

4.2

1.5

1.6

0.70

317

2162

(3020961) Endomysium IgA Ab [Titer] in Serum

420

2850

1.50

12.93

1.2

titre

448.0

208.4

—

(3021901) Oxygen saturation in Capillary blood

363

2.39

12.83

2.4

3.9

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

253

1532

1.67

12.73

1.5

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

194

2.92

12.59

1.9

2.2

nmol/l

127.6

143.8

0.55

162

(3017509) Phencyclidine [Presence] in Urine

3.83

12.51

1.4

1.7

—

(3012516) Albumin [Mass/volume] in Urine

619

4554

1.39

12.32

3.2

3.7

mg/l

411.3

448.7

0.07

416

3230

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

166

900

1.85

12.29

1.2

1.8

mmol/l

3.6

3.5

0.99

158

844

(3035637) Corticotropin [Mass/volume] in Plasma

115

555

2.07

11.94

1.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

211

3364

0.60

11.72

1.4

1.6

—

(4010399)

281

1787

1.59

11.62

1.4

—

(3003338) MCHC [Mass/volume]

3868

36117

1.31

11.37

15.2

10.9

g/l

334.4

334.5

0.30

3848

35759

(3048929) Epstein Barr virus Ab [Presence] in Serum

431

3018

1.45

11.30

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

238

1468

1.63

11.17

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

198

3156

0.60

10.98

1.7

1.8

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

188

2.80

10.91

1.5

1.6

nmol/l

1.1

1.8

1.80

147

(3003327) Ova and parasites identified in Stool by Light microscopy

280

1822

1.55

10.49

1.9

1.7

—

(40761535) Cells panel - Urine sediment

281

1830

1.55

10.49

3.2

3.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1596

13590

1.24

10.49

3.2

2.8

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

360

5003

0.69

10.49

1.4

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

164

932

1.76

10.45

5.1

4.7

0.7

0.55

155

907

(3004119) Hemoglobin [Mass/volume] in Venous blood

196

1178

1.67

10.20

5.1

4.8

g/l

132.8

134.7

0.61

191

1152

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

166

956

1.74

10.11

11.3

12.3

—

(3016018) Differential panel - Cerebral spinal fluid

454

2.06

9.81

1.2

2.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

364

2.19

9.74

1.2

1.1

—

(3023520) Reticulocytes [#/volume] in Blood

246

1585

1.56

9.65

2.6

3.4

e9/l

67.3

70.3

0.59

165

1090

(3008295) Osmolality of Serum or Plasma

291

2.33

9.57

1.8

2.1

mosm/kgh2o

290.6

290.3

0.06

226

(44813793)

420

2.09

9.49

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

138

773

1.78

9.27

1.2

1.3

u/ml

45.5

38.7

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

236

1522

1.56

9.23

1.3

—

(3023410) Appearance of Cerebral spinal fluid

480

1.97

8.80

1.3

2.6

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

247

3569

0.67

8.78

1.4

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

322

2.19

8.75

1.1

u/ml

126.8

22.5

0.41

224

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

249

3586

0.67

8.71

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

250

3592

0.67

8.64

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

171

1039

1.65

8.59

2.0

1.9

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

250

3588

0.67

8.59

1.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

142

822

1.73

8.55

3.8

4.1

mmol/l

25.1

24.9

0.37

136

788

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

157

936

1.68

8.49

2.0

1.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

262

1761

1.50

8.48

1.6

1.7

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

152

900

1.69

8.43

2.2

2.1

—

(3052851) Hemolysis interference index of Serum or Plasma

141

818

1.72

8.43

2.7

2.9

—

(40768804) Tissue Pathology biopsy report

1376

11768

1.22

8.22

1.9

1.8

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

319

2242

1.43

8.21

1.5

1.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

180

1121

1.61

8.21

1.5

2.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

251

3562

0.68

8.13

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

157

948

1.66

8.10

1.5

1.4

u/l

12.1

14.6

0.64

115

828

(3008152) Bicarbonate [Moles/volume] in Arterial blood

160

973

1.64

8.03

5.4

7.1

mmol/l

24.2

24.0

0.48

151

907

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

171

1061

1.61

7.93

2.7

3.1

ng/l

82.2

97.7

0.33

138

906

(3020891) Body temperature

120

678

1.77

7.89

4.2

4.8

—

(3011985) Renin [Units/volume] in Plasma

350

2.08

7.85

1.8

1.6

mu/l

48.3

77.7

1.58

313

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

143

853

1.67

7.75

1.2

1.3

u/ml

3.9

18.3

2.74

124

(3019060) Gas panel - Arterial blood

154

941

1.64

7.61

3.9

5.4

—

(3016244) Insulin [Units/volume] in Serum or Plasma

100

542

1.84

7.56

2.6

3.4

mu/l

23.5

28.2

0.86

509

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

283

3875

0.70

7.53

1.4

1.5

—

(3024928) Oxygen saturation in Venous blood

515

1.86

7.50

6.5

5.9

—

(3020630) Protein [Mass/volume] in Serum or Plasma

179

1140

1.57

7.46

1.4

2.1

g/l

67.5

67.8

0.27

164

1085

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

190

1228

1.55

7.42

1.7

1.9

g/l

0.2

0.24

180

1171

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

193

1252

1.54

7.42

1.7

1.9

g/l

1.2

0.38

184

1194

(3021879) Hepatitis B virus core Ab [Presence] in Serum

640

5087

1.28

7.33

1.6

1.5

—

(3006653) Thiamine [Moles/volume] in Blood

125

2.78

7.22

1.7

1.4

nmol/l

131.9

138.7

0.36

125

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

139

841

1.65

7.16

1.2

1.3

u/ml

1.6

8.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

416

3128

1.34

7.15

2.5

2.3

ug/l

1.0

1.2

2.26

366

2891

(3006270) Folate [Moles/volume] in Blood

189

2.36

6.72

1.1

nmol/l

409.2

415.8

0.07

184

(3001186) Copper [Moles/volume] in Serum or Plasma

109

2.82

6.61

1.4

1.5

umol/l

17.9

16.6

0.50

100

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

217

1481

1.47

6.58

1.4

—

(40761536) Microorganisms panel - Urine sediment

434

3324

1.32

6.57

3.5

3.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

341

1.98

6.54

1.5

1.4

pmol/l

367.7

352.8

0.10

272

(3024980) IgG subclass 4 [Mass/volume] in Serum

114

674

1.69

6.45

1.6

1.8

g/l

0.7

0.01

525

(3044640) Blood type and Crossmatch panel - Blood

1157

9922

1.20

6.45

2.3

2.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

207

1413

1.47

6.28

1.5

1.4

u/ml

240.9

216.3

0.63

122

846

(3026389) Candida sp identified in Specimen by Organism specific culture

511

1.77

6.20

1.2

1.3

—

(4062490)

435

1.83

6.07

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

250

2.10

6.04

1.1

—

(3000492) Spirometry study

485

3815

1.28

6.02

1.4

1.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

422

1.84

6.01

4.4

3.6

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

264

2.07

5.99

1.6

1.4

ug/l

5.3

5.9

0.43

230

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

213

2.19

5.92

1.6

1.7

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

100

586

1.70

5.88

1.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

440

1.81

5.86

1.4

g/l

6.5

0.01

317

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

100

587

1.70

5.85

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

117

1813

0.63

5.85

1.1

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

573

1.70

5.82

1.4

1.3

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

384

1.86

5.82

3.6

2.9

95.2

94.7

0.05

361

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

507

1.75

5.80

1.7

1.9

ug/l

1.8

1.5

0.10

454

(40759836) Histone Ab [Presence] in Serum by Immunoblot

322

1.94

5.78

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

105

627

1.67

5.77

2.4

2.9

nmol/l

0.9

0.7

1.33

548

(3011897) Casein IgE Ab [Units/volume] in Serum

203

2.20

5.75

1.4

1.3

u/ml

0.3

12.6

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

323

1.94

5.74

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

323

1.94

5.74

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

323

1.94

5.74

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

416

3231

1.30

5.70

1.3

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

394

1.84

5.69

1.3

pmol/l

98.4

54.8

0.53

102

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

324

1.93

5.69

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

338

1.91

5.68

1.3

1.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

179

2.27

5.66

1.5

u/l

5.4

6.3

0.49

150

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

325

1.93

5.64

1.2

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

4.59

5.62

1.0

ng/l

198.8

217.2

0.23

(3024139) IgG subclass 3 [Mass/volume] in Serum

439

1.79

5.61

1.4

g/l

0.3

0.4

0.63

315

(3028192) IgG subclass 2 [Mass/volume] in Serum

440

1.79

5.57

1.4

g/l

2.7

2.8

0.13

316

(3043409) Potassium [Moles/volume] in Arterial blood

462

1.77

5.56

3.2

3.8

mmol/l

3.7

3.8

0.79

432

(3035320) C reactive protein [Mass/volume] in Body fluid

268

2.00

5.41

2.2

2.1

—

(3000034) Microalbumin [Mass/volume] in Urine

158

2.32

5.39

2.5

2.9

mg/l

49.5

56.8

0.12

118

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

216

2.11

5.34

1.0

1.1

u/ml

6.2

15.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

119

749

1.58

5.33

1.3

1.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1204

10510

1.18

5.33

2.8

2.5

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

304

1.93

5.32

1.1

1.2

—

82.7

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

123

782

1.57

5.28

1.6

1.7

titre

2240.0

3336.7

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

211

2852

0.72

5.23

1.4

1.5

—

(3025941) Bacteria identified in Stool by Culture

327

2491

1.32

5.18

1.3

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1016

8764

1.18

5.17

1.6

1.5

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

322

1.88

5.13

1.1

mg/l

276.5

282.5

0.25

297

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

2.85

5.06

1.3

1.5

nmol/l

108.1

95.1

0.18

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

116

1741

0.65

5.05

1.2

1.3

ug/l

4.9

4.0

0.40

111

1653

(3005033) Fetal Nuchal fold Thickness US

212

2843

0.72

5.02

1.4

1.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

237

1732

1.37

4.97

1.1

u/ml

4.8

8.1

2.62

149

1090

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

270

1.95

4.97

1.1

1.4

u/l

10.8

24.7

0.90

238

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

167

1151

1.45

4.90

1.5

1.6

u/ml

98.2

101.3

0.16

191

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

102

634

1.60

4.85

4.0

6.2

1.8

0.14

585

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

4.24

4.73

2.8

1.5

nmol/l

23.1

19.7

0.10

(3043238) Trisomy 21 risk [Likelihood] in Fetus

222

2925

0.74

4.70

1.4

1.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

325

1.83

4.69

1.1

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

327

1.82

4.61

1.1

1.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.72

4.49

1.1

u/ml

0.0

0.55

(3049233) Organic acids panel - Urine

4.35

4.47

1.1

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

192

2.07

4.45

1.2

1.1

nmol/l

0.2

4.8

—

(3032641) Amino acids panel - Urine

4.71

4.44

1.1

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

147

2.22

4.42

1.2

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

171

1209

1.41

4.40

1.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

333

1.79

4.36

1.1

1.7

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

216

1592

1.36

4.33

1.1

u/ml

3.0

4.2

0.39

249

(3002256) Pathology report gross observation

422

3399

1.25

4.33

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

228

1696

1.34

4.31

1.1

u/ml

2.9

3.0

0.05

508

(3024522) Salmonella sp identified in Specimen by Organism specific culture

349

1.76

4.31

1.3

1.4

—

(3028717) Thiamine [Mass/volume] in Blood

4.18

4.27

1.1

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

209

1.99

4.25

1.1

1.2

—

(3045414) Leukocytes [Presence] in Urine

184

1327

1.38

4.23

1.7

1.6

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

359

1.74

4.21

1.3

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

396

1.70

4.20

1.3

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

489

1.63

4.13

1.1

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

120

2.31

4.11

2.3

2.6

nmol/l

1.3

1.4

0.14

104

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

475

1.63

4.09

1.1

g/l

1.4

0.39

432

(3006184) Hemoglobin [Mass/volume] in Capillary blood

568

1.57

4.07

1.9

2.2

g/l

142.0

134.4

2.60

452

(3008401) Mugwort IgE Ab [Units/volume] in Serum

221

1654

1.33

4.03

1.1

u/ml

1.5

1.3

0.08

130

889

(3003181) Sodium [Moles/volume] in Urine

270

1.84

4.00

1.8

2.7

mmol/l

67.3

80.4

1.24

229

(3005988) Vibrio sp identified in Specimen by Organism specific culture

350

1.73

3.99

1.2

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

350

1.73

3.99

1.2

1.4

—

(3023420) DNA double strand Ab [Units/volume] in Serum

426

1.65

3.95

1.8

1.7

iu/ml

27.3

29.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

257

1.85

3.95

1.1

1.2

u/ml

5.8

11.9

0.46

194

(3025130) Human papilloma virus identified in Specimen

116

781

1.48

3.92

1.6

1.8

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.57

3.86

4.1

2.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

317

1.75

3.86

1.1

1.3

u/ml

0.0

0.6

2.32

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

354

1.71

3.85

1.2

1.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

3.09

3.83

1.3

1.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1749

15972

1.13

3.83

3.9

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

178

1301

1.36

3.81

1.7

2.0

u/l

38.6

39.9

0.42

158

1235

(3025468) Yersinia sp identified in Specimen by Organism specific culture

348

1.71

3.80

1.3

1.4

—

(3047181) Lactate [Moles/volume] in Blood

643

1.51

3.76

4.0

5.9

mmol/l

1.2

0.01

555

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

636

1.52

3.74

1.3

1.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

865

7546

1.16

3.74

2.2

2.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

380

1.67

3.73

1.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

449

1.61

3.71

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

228

1.87

3.67

3.1

2.7

umol/l

60.9

51.2

1.06

205

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

149

1065

1.39

3.67

1.9

2.2

iu/l

3.7

4.1

0.21

446

(3036489) Thrombin time

200

1498

1.33

3.66

2.7

3.3

20.7

21.4

1.88

177

1278

(4034850)

121

835

1.44

3.63

7.9

6.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

174

1287

1.35

3.48

1.6

nmol/l

0.3

0.5

4.89

149

1089

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

246

1913

1.28

3.44

1.2

1.1

u/ml

2.4

2.3

0.04

136

959

(3040151) Glucose [Moles/volume] in Capillary blood

307

1.71

3.41

1.4

6.2

mmol/l

7.1

6.4

0.54

247

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

352

1.66

3.41

1.4

1.3

titre

353.0

257.0

—

(4027681)

391

1.62

3.37

1.4

1.2

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

2.44

3.36

1.0

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

480

1.55

3.27

1.2

1.1

mg/l

38.9

36.7

0.16

396

(3010144) Erythrocytes [#/volume] in Synovial fluid

134

2.07

3.22

1.4

e6/l

13272.2

31533.4

0.49

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

381

1.61

3.21

1.4

1.5

g/l

10.0

10.5

0.44

334

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

2.59

3.21

2.5

2.7

ug/g

222.0

174.1

0.57

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

4.68

3.20

1.3

1.5

nmol/l

342.8

556.8

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

176

1323

1.33

3.19

3.3

3.5

154.9

160.8

0.44

164

1263

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

414

1.58

3.15

1.4

g/l

3.5

3.8

1.99

308

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

414

1.58

3.15

1.4

g/l

6.9

7.2

0.91

327

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

414

1.58

3.15

1.4

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

142

2.02

3.15

1.3

1.5

pmol/l

12.7

14.1

0.87

119

(3033942) Copper [Moles/time] in 24 hour Urine

3.12

3.14

1.2

1.3

umol/24h

0.2

0.5

—

(3014051) Protein [Presence] in Urine by Test strip

646

1.46

3.13

1.9

1.8

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

400

1.59

3.11

1.4

1.5

g/l

2.7

3.1

1.82

321

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

456

1.54

3.07

1.7

1.8

—

(3001556) Androgen free Index in Serum or Plasma

137

2.02

3.05

1.3

1.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

2.38

3.04

1.8

2.6

umol/l

29.3

29.0

0.03

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

489

1.52

3.03

1.0

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

466

1.53

3.01

1.1

mg/l

202.6

220.8

0.55

405

(3000330) Specific gravity of Urine by Test strip

143

1052

1.35

3.01

2.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

684

1.44

3.01

1.6

1.5

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

208

1.81

3.00

1.2

1.1

93.3

94.2

0.06

(3041672) Baker's yeast Ab [Presence] in Serum

2.65

2.97

1.2

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

4.24

2.95

1.8

1.7

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.86

2.95

9.5

7.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

298

1.66

2.94

1.3

1.5

g/l

0.0

0.00

284

(3020874) Milk IgE Ab [Units/volume] in Serum

549

1.48

2.94

1.1

u/ml

0.5

4.1

2.28

227

(3007930) Methemoglobin/Hemoglobin.total in Blood

632

1.45

2.90

4.0

6.2

0.9

0.25

584

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

102

717

1.41

2.84

1.1

iu/ml

22.1

2085.3

0.99

236

(3022621) pH of Urine by Test strip

240

1912

1.25

2.81

2.3

2.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

223

1762

1.26

2.80

2.4

2.2

ml/min/173m2

85.3

86.3

0.12

634

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

557

1.46

2.75

1.2

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

2.75

0.0

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

178

1.84

2.75

1.1

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

351

1.58

2.73

1.4

1.5

g/l

0.7

0.4

0.37

328

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

2.37

2.72

2.0

3.5

mg/l

21.8

26.7

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

298

1.63

2.70

1.3

1.5

g/l

0.0

0.00

284

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

578

1.44

2.65

1.4

1.3

umol/l

6.3

6.2

0.08

531

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

145

1.91

2.64

1.1

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

949

0.67

2.64

1.5

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

498

1.47

2.62

1.0

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.21

2.62

1.2

1.4

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

203

1.76

2.61

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

218

1.73

2.60

1.2

1.1

94.7

93.4

0.14

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

317

1.59

2.59

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.76

2.58

1.4

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

333

1.58

2.57

1.2

1.5

g/l

0.0

0.50

318

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

318

1.59

2.56

1.3

1.5

g/l

40.1

39.8

0.16

293

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.43

2.54

6.3

5.2

—

(3013336) Amino acids [Identifier] in Serum or Plasma

2.43

2.54

2.8

2.7

—

(1761482) Bacteria [#/volume] in Urine by Culture

390

1.53

2.52

2.7

2.6

—

(3051611) Lipemic interference index of Serum or Plasma

258

1.65

2.51

3.2

4.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

304

1.60

2.51

1.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

176

1372

1.28

2.50

3.7

3.9

g/l

3.2

3.3

0.46

161

1311

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

101

727

1.38

2.50

1.2

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

2.39

2.46

7.1

5.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

322

1.57

2.44

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

4.32

2.44

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

284

1.60

2.42

1.0

u/ml

2.5

9.2

—

(3051651) Icteric interference index of Serum or Plasma

209

1.71

2.39

3.2

4.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

301

1.58

2.37

1.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

356

0.50

2.37

5.1

6.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

356

0.50

2.37

2.6

3.0

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

240

1.65

2.36

5.9

7.4

mg/l

9.3

9.4

0.08

217

(3039443) Prostate specific Ag panel - Serum or Plasma

379

0.52

2.32

1.4

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.23

2.27

2.8

1.9

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

664

1.37

2.27

1.6

1.7

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

202

1624

1.24

2.24

1.6

1.5

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

2.16

2.23

1.3

1.4

1.7

8.8

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

147

1.82

2.23

1.5

1.6

32.2

41.0

0.57

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

410

1.47

2.22

1.8

1.6

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

133

1.86

2.22

1.0

1.1

u/ml

0.3

1.5

0.87

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

109

811

1.33

2.22

1.7

2.2

mg/l

9.2

9.7

0.46

100

777

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

283

2356

1.20

2.22

2.3

2.2

22.7

21.4

0.35

494

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

112

1.94

2.22

1.2

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

119

1.91

2.22

2.7

1.6

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

297

2484

1.19

2.21

4.3

4.5

u/l

210.6

237.7

4.62

282

2379

(3011648) Oxygen content in Venous blood

260

1.60

2.21

7.7

8.0

12.4

11.6

0.64

260

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

412

1.47

2.18

1.3

1.5

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

277

1.57

2.17

1.3

1.2

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

121

1.88

2.12

1.0

1.1

u/ml

0.0

0.6

1.36

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

172

1.73

2.11

1.2

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

172

1.73

2.11

1.2

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

172

1.73

2.11

1.2

1.7

—

(3034988) Calcium [Moles/volume] in Capillary blood

2.08

2.05

3.7

5.8

mmol/l

1.2

0.66

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.08

2.05

3.6

4.5

—

(3017732) Neutrophils [#/volume] in Blood

283

2376

1.19

2.04

2.1

2.0

e9/l

4.0

4.2

1.45

213

2063

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

227

1.61

2.04

1.9

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

437

0.58

2.03

1.4

1.9

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

182

1.69

2.02

1.3

1.2

g/l

0.3

0.54

143

(3037121) Protein [Mass/volume] in Urine

139

1086

1.27

2.01

4.6

4.7

g/l

0.3

0.4

1.42

605

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

160

1.73

2.00

1.7

1.5

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

178

1436

1.23

1.95

3.2

4.0

95.4

94.5

0.22

165

1336

(3014599) Egg white IgE Ab [Units/volume] in Serum

547

1.38

1.95

1.1

u/ml

1.1

8.4

1.19

200

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.98

1.93

1.0

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

399

1.44

1.92

1.5

1.8

e6/l

5465.0

11730.4

1.53

290

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

669

1.33

1.89

1.7

1.8

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.16

1.88

1.1

1.3

ng/l

9.3

26.3

—

(3016031) Almond IgE Ab [Units/volume] in Serum

1.96

1.88

1.1

1.0

u/ml

0.5

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

106

809

1.30

1.86

6.4

6.3

iu/ml

968.8

777.9

0.13

(3002619) Bacteria identified in Specimen by Culture

2.09

1.86

1.1

1.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.14

1.85

3.4

2.3

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

226

1.58

1.84

1.8

1.6

nmol/l

4.4

5.7

2.11

216

(3024891) Influenza virus A+B Ag [Presence] in Specimen

169

1367

1.23

1.83

1.2

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

2.62

1.83

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

274

1.52

1.82

1.6

1.5

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

136

1.75

1.79

3.4

2.3

mmol/l

1.4

2.2

0.62

106

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

198

1.60

1.74

1.3

1.2

u/l

99.4

76.1

0.39

135

(3015076) Soybean IgE Ab [Units/volume] in Serum

492

1.37

1.73

1.1

u/ml

0.2

1.8

1.17

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

270

1.50

1.71

1.3

1.7

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.88

1.69

1.3

2.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

336

1.44

1.69

1.3

1.6

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

297

1.47

1.65

1.0

1.1

u/l

0.9

1.0

0.28

121

(40768443) Skin Pathology biopsy report

140

1126

1.23

1.63

1.1

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

1029

0.76

1.62

1.5

1.6

mmol/l

7.8

7.4

0.77

629

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

133

1.71

1.62

1.0

1.1

u/ml

0.2

4.8

0.96

(3014133) Dog dander IgE Ab [Units/volume] in Serum

164

1342

1.21

1.62

1.1

u/ml

7.9

5.6

0.33

636

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

193

1605

1.19

1.61

1.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

185

0.48

1.61

1.1

1.2

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

3.53

1.59

1.2

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

211

1771

1.18

1.59

1.8

ug/l

0.4

0.5

2.82

110

689

(3022493) Free Hemoglobin [Mass/volume] in Plasma

157

1.64

1.58

9.4

5.7

mg/l

77.6

75.5

0.06

125

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

383

1.40

1.57

1.4

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.82

1.55

2.0

1.6

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

131

1055

1.23

1.53

2.9

4.0

ug/l

2.2

48.5

0.66

700

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

238

1.50

1.51

1.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

3.29

1.50

2.0

1.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

114

1.73

1.50

1.5

1.7

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

207

1.53

1.48

1.5

1.7

57.6

47.4

0.64

153

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

396

1.38

1.48

2.4

4.2

u/ml

24.1

113.2

2.35

126

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

115

1.72

1.46

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.81

1.45

2.2

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

225

1.49

1.43

1.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

349

1.39

1.41

2.2

3.1

1.8

1.1

0.54

282

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

425

1.35

1.41

1.6

1.7

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

226

1.49

1.41

1.5

2.2

mg/l

38.8

27.6

0.31

179

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

755

1.26

1.40

3.3

3.9

55.9

55.0

0.28

755

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

350

1.39

1.9

1.7

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

546

1.31

1.39

1.6

1.5

mmol/l

15.3

11.2

1.35

(3017315) Amylase [Enzymatic activity/volume] in Urine

171

1.56

1.38

1.1

1.3

u/l

305.2

391.8

0.30

156

(3044242) Glucose [Moles/volume] in Arterial blood

1.90

1.38

1.4

3.0

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

376

1.37

1.38

1.9

2.6

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

130

1060

1.22

1.37

1.1

u/ml

0.3

0.4

0.33

291

(3023430) Cat dander IgE Ab [Units/volume] in Serum

149

1232

1.20

1.37

1.1

u/ml

12.9

7.4

0.73

616

(3004616) Nuclear Ab [Presence] in Serum

335

1.39

1.36

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

352

1.38

1.36

1.5

1.6

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

212

1.49

1.35

1.5

1.8

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.83

1.35

1.5

1.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

2.90

1.34

1.0

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

438

1.33

1.7

1.5

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

1.33

0.0

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

111

1.69

1.33

2.0

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

347

1.37

1.29

1.6

1.5

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.47

1.28

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

2.32

1.28

1.8

2.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.76

1.27

1.0

—

(40768446) Kidney Pathology biopsy report

175

1.53

1.27

2.0

1.9

—

(3024869) Neuronal Ab [Presence] in Serum

2.74

1.26

1.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.74

1.26

1.0

1.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

136

1.60

1.26

2.5

5.1

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

743

1.24

1.22

3.2

3.6

e9/l

3.8

0.02

743

(3035880) pH of Pleural fluid

2.37

1.22

1.2

1.1

—

(40768441) Liver Pathology biopsy report

234

1.44

1.22

1.7

1.6

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

226

1.44

1.21

1.5

2.2

mg/l

29.7

34.1

0.30

179

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

2.60

1.20

2.2

1.9

—

1.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.88

1.18

1.4

1.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

203

1.46

1.17

1.6

—

(3044941) Cell count panel - Synovial fluid

286

1.38

1.17

1.3

1.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

179

1.49

1.17

1.6

2.2

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

1.16

0.0

1.0

—

17.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

363

1.34

1.16

1.1

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

101

1.66

1.14

2.1

1.6

—

(1761868) Lipid panel - Serum or Plasma

1317

13579

0.94

1.12

2.2

1.9

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

1.68

1.12

1.1

u/ml

14.2

8.8

0.36

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

118

1.59

1.09

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.66

1.09

4.0

2.9

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

158

1.50

1.08

1.0

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

165

1874

0.86

1.07

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

308

1.35

1.07

1.8

1.5

—

(3010838) Calcium [Moles/time] in 24 hour Urine

1.65

1.05

1.6

—

6.0

—

(3000012) Reticulocyte production index

1.65

1.05

1.1

1.4

—

(3044927) Protein electrophoresis panel - Urine

1.71

1.04

1.0

—

(3014271) Vancomycin [Susceptibility]

2.10

1.04

2.6

1.8

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

1.67

1.03

1.7

1.5

ug/min

34.2

56.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

243

1.38

1.02

2.8

1.5

mg/l

17.5

26.0

0.79

(3005011) Chlamydia sp Ab [Titer] in Serum

1.63

1.02

1.7

1.3

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.03

1.01

1.0

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

174

1503

1.15

1.01

1.1

1.2

—

(1175426) CD3 cells/100 lymphocytes in Blood

407

1.29

1.00

1.8

2.5

74.5

72.7

0.44

396

(21494814) CD8 cells/100 lymphocytes in Specimen

121

1.55

1.00

1.4

2.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

886

9215

0.94

1.00

1.6

1.5

—

(3049717) Cytology report of Urine Cyto stain

321

1.33

1.00

1.3

1.7

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.85

0.99

2.9

1.6

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

1.85

0.99

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.86

0.97

1.2

1.4

pmol/l

472.0

311.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.63

0.96

1.1

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

155

1.47

0.95

1.0

1.1

mg/g

4.5

5.7

1.41

150

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3896

38010

1.07

0.94

4.4

4.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

116

0.51

0.94

1.5

2.8

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

101

842

1.19

0.93

1.8

2.1

g/l

1.3

1.2

0.35

738

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.19

0.92

1.2

1.6

umol/24h

277.3

271.6

—

(4024509)

218

0.63

0.92

1.1

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

148

1.47

0.92

1.2

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

404

1.27

0.92

1.9

2.2

—

(3021788) Differential panel - Synovial fluid

344

1.29

0.90

1.5

1.6

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

524

0.77

0.90

1.0

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

512

1.24

0.89

3.3

4.1

u/ml

7.0

5.1

0.29

440

(3011412) CD3 cells [#/volume] in Blood

477

1.24

0.89

1.9

2.9

e9/l

1.6

1.3

0.91

277

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

647

1.21

0.89

6.3

4.8

u/ml

245.6

1138.2

—

(3024471) HLA-A [Type]

150

1.45

0.87

1.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.72

0.86

11.2

7.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1428

13618

1.05

0.83

1.9

1.8

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

202

1.37

0.83

1.3

1.7

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.91

0.83

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.91

0.83

4.7

6.0

mmol/l

5.7

6.3

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

402

1.25

0.82

1.9

2.5

9.8

11.4

0.78

280

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.70

0.82

3.0

2.2

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

690

0.81

0.82

1.2

1.4

nmol/l

18.5

32.3

3.89

634

(3038177) Helicobacter pylori Ab [Presence] in Serum

772

1.18

0.81

1.2

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

336

0.73

0.80

2.9

3.1

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

0.79

0.0

12.2

—

153.3

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.62

0.78

1.6

1.2

—

(44790049)

415

1.24

0.77

1.6

1.7

—

(44790047)

415

1.24

0.77

1.6

1.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

433

1.23

0.77

2.1

2.6

—

(44806118)

416

1.24

0.76

1.6

1.7

—

(44790048)

416

1.24

0.76

1.6

1.7

—

(3025315) Body weight

2.15

0.75

2.6

2.7

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

1.65

0.75

1.5

1.7

nmol/l

4.1

466673.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.57

0.74

1.2

2.2

—

(4038314)

1.54

0.74

1.1

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.54

0.74

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.54

0.74

2.7

3.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

734

1.17

0.74

1.2

1.3

u/ml

2.2

4.8

1.43

278

(4094501)

418

1.23

0.73

1.0

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

123

1.45

0.73

1.8

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

199

1.34

0.73

1.8

2.9

60.0

53.7

0.85

129

(3001019) Free T4 and TSH panel - Serum or Plasma

286

3059

0.92

0.72

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.62

0.72

2.4

1.2

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

105

0.56

0.72

1.0

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

107

1.48

0.72

1.1

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

107

1.48

0.72

1.1

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

107

1.48

0.72

1.1

2.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

107

1.48

0.72

1.1

2.0

—

(3051593) INR in Capillary blood by Coagulation assay

1.97

0.72

1.0

6.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.62

0.72

2.5

2.6

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.77

0.72

4.7

4.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

149

1.39

0.71

1.8

2.1

—

(3024932) HLA-DR beta [Type]

149

1.39

0.71

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

655

0.83

0.70

1.6

2.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.90

0.70

1.0

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

448

1.21

0.69

4.4

7.6

u/ml

0.3

0.43

226

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1045

0.87

0.68

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

117

1.44

0.67

9.2

7.3

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

1.83

0.67

2.4

2.0

mmol/l

8.0

5.6

—

(3009677) Dengue virus Ab [Presence] in Serum

1.83

0.67

1.0

1.2

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

134

1.40

0.67

1.1

1.0

u/ml

0.0

0.1

0.80

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

311

2853

1.08

0.66

1.4

1.3

miu/ml

236.5

237.8

0.02

110

1436

(3003694) ABO and Rh group [Type] in Blood

1397

14196

0.96

0.66

1.6

1.8

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

133

1470

0.89

0.66

1.6

1.7

iu/ml

4.2

0.2

0.45

294

(4306422)

698

1.16

0.65

1.1

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

717

1.16

0.64

1.3

u/ml

4.0

4.5

0.17

342

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

152

1.37

0.64

1.1

—

(3042733) HLA Ab [Presence] in Serum

144

1.37

0.63

5.0

4.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

739

1.15

0.61

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.61

0.61

1.0

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

440

0.81

0.61

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.60

0.0

1.1

—

35.2

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.60

0.0

5.7

—

0.2

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.60

0.0

2.8

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.60

0.0

1.1

—

71.7

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.55

0.59

1.4

1.9

—

(3017704) Immunofixation for Urine

1.55

0.59

1.4

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.50

0.59

1.2

2.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.50

0.59

1.2

2.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.59

0.0

1.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.49

0.57

1.6

1.7

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

113

1.40

0.57

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.69

0.57

1.5

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

261

1.25

0.57

1.2

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.48

0.56

1.3

2.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

170

1535

1.10

0.55

2.9

2.5

umol/l

7.2

5.7

0.49

122

1167

(3014148) Varicella zoster virus Ab [Titer] in Serum

1003

0.88

0.54

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

166

1.31

0.54

1.3

1.2

—

(3013637) Mi-2 Ab [Presence] in Serum

1.51

0.54

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.51

0.54

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.51

0.54

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.51

0.54

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

667

0.86

0.54

2.5

2.6

mg/l

27.6

24.7

0.23

415

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

299

1.22

0.54

1.4

1.7

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.56

0.53

1.0

1.1

—

(44806071)

1.52

0.52

1.1

1.0

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

113

1004

1.11

0.51

1.1

au/ml

23.3

9.9

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

1.48

0.51

1.0

1.1

—

2.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

236

2495

0.93

0.50

2.3

2.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

406

1.17

0.46

1.2

1.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

154

1.28

0.45

1.1

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.38

0.44

1.0

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

426

1.16

0.44

1.1

1.2

—

(3024263) Appearance of Synovial fluid

1.39

0.44

1.4

2.7

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

362

1.17

0.44

1.9

3.0

e6/l

947.4

864.9

0.22

119

(3004775) Volume in Urine collected for unspecified duration

120

1.32

0.43

1.6

2.4

758.7

666.9

0.42

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.59

0.42

1.2

1.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

1.59

0.42

3.0

2.5

pmol/l

63.4

41.3

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.59

0.42

1.0

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.59

0.42

1.0

1.9

—

(3016750) Collection duration of Urine

103

1.34

0.42

1.5

2.5

min

527.2

515.7

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.43

0.42

1.1

2.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.43

0.42

1.1

2.2

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.41

0.0

1.0

—

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

0.00

0.41

0.0

4.7

—

17.8

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.41

0.0

1.9

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.41

0.0

1.1

—

28.5

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.41

0.0

1.0

—

(3013762) Body weight Measured

0.00

0.41

0.0

1.3

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.50

0.41

1.0

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.50

0.41

1.4

2.0

ng/l

70.3

103.0

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.45

0.40

1.2

1.3

—

3.4

—

(3022689) Creatine [Moles/volume] in Urine

1.35

0.38

1.0

1.8

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

297

0.83

0.37

1.1

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

123

1.28

0.37

1.5

u/l

5.1

3.7

—

(1617658) Protocol used for examination of sentinel lymph nodes

114

0.69

0.37

1.0

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

159

1.24

0.36

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

195

1.22

0.36

1.1

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.29

0.36

1.0

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.29

0.36

1.2

1.4

—

(40768795) Lymph node Pathology biopsy report

221

0.80

0.36

1.1

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

268

1.18

0.36

1.1

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

391

0.86

0.36

1.1

1.3

—

(3045424) Erythrocytes [Presence] in Urine

519

1.12

0.36

1.3

1.4

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

177

0.78

0.36

1.3

1.2

—

(3006598) pH of Arterial cord blood

0.62

0.35

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.41

0.35

1.2

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

408

1.14

0.35

2.1

2.9

e9/l

0.2

0.24

323

(3008757) Leukocyte morphology finding [Identifier] in Blood

297

1.16

0.35

1.9

3.2

—

(4211845)

161

1.23

0.33

1.9

2.1

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

289

1.16

0.33

2.1

2.6

26.2

27.8

0.50

283

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.35

0.32

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

417

0.87

0.31

2.6

2.7

ug/min

56.3

126.9

1.28

277

(3017569) Oxygen content in Arterial blood

1.28

0.30

2.4

3.5

—

(3006462) Nitrate [Presence] in Urine

146

1.22

0.29

2.0

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

425

1.12

0.28

1.4

2.2

—

(4281824)

181

0.82

0.28

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.27

0.27

1.2

—

(40765096) Chromosome analysis panel by Banding

1.25

0.27

1.1

—

(40768793) Breast Pathology biopsy report

568

1.10

0.27

1.2

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.20

0.26

1.0

1.2

—

(4146454)

121

1.22

0.26

3.7

3.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.28

0.26

1.5

ug/l

10.5

8.0

1.77

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

213

1.16

0.25

2.1

2.6

45.4

43.7

0.14

(3023419) Bacteria identified in Sputum by Culture

179

0.83

0.25

1.3

4.1

—

(3020650) Glucose [Presence] in Urine

136

0.80

0.25

1.4

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

1.18

0.24

1.6

1.7

u/l

8.1

12.2

—

(4268621)

515

1.09

0.24

2.1

2.4

—

(3015183) Erythrocyte sedimentation rate

314

0.88

0.24

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

412

1.10

0.23

2.1

2.9

e6/l

499.8

518.7

0.14

321

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

206

1.15

0.23

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

229

0.86

0.22

1.1

106.6

88.5

2.12

181

(3003740) Influenza virus B Ag [Presence] in Specimen

111

1158

0.94

0.22

1.0

1.1

—

(4035726)

184

1741

1.04

0.22

1.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

342

0.89

0.21

1.1

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

133

1379

0.95

0.21

1.8

1.9

—

(3038702) Sodium [Moles/volume] in Capillary blood

0.00

0.21

0.0

3.7

—

139.4

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.21

0.0

5.6

—

(4212803)

0.00

0.21

0.0

1.0

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

339

1.11

0.21

2.8

3.5

au/ml

301.8

112.4

—

(3028433) Virus identified in Specimen by Culture

124

1.19

0.21

1.0

1.2

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.21

0.0

8.8

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

175

0.85

0.21

1.9

2.3

u/field

3.1

1.5

—

105

(3019174) dRVVT (LA screen)

1.23

0.20

1.3

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

142

0.83

0.19

1.1

3.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

142

0.83

0.19

1.1

3.2

—

(3044009) aPTT.lupus sensitive (LA screen)

1.18

0.19

1.3

1.2

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

135

1.17

0.19

1.8

mg/l

4.1

2.6

0.39

127

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.22

0.19

1.6

5.6

—

(4133840)

120

0.82

0.18

1.0

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

307

0.90

0.18

1.0

1.1

miu/ml

1707.4

1485.0

0.41

307

(3045142) Bone marrow Pathology biopsy report

214

0.88

0.18

1.4

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1220

12182

0.98

0.18

1.9

1.8

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

930

1.05

0.17

1.1

u/ml

3.0

3.1

0.03

468

(40758292) HTLV I+II Ab panel - Serum

1.21

0.17

1.0

1.2

—

(3034426) Prothrombin time (PT)

165

1.14

0.16

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

181

0.87

0.16

1.7

1.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

1.11

0.16

1.3

g/l

41.0

37.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.79

0.15

1.0

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.78

0.15

1.0

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

740

0.95

0.15

1.4

1.6

mmol/l

6.1

6.6

1.20

522

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.77

0.15

1.0

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.14

0.15

1.0

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.18

0.14

1.1

1.2

—

(3030313) Adrenal Ab [Titer] in Serum

1.18

0.14

1.4

1.1

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

196

1.11

0.13

2.0

2.1

au/ml

58.3

156.7

—

(3002523) Influenza virus A Ag [Presence] in Specimen

113

1158

0.96

0.13

1.0

1.1

—

(3038026) Centromere Ab [Units/volume] in Serum

197

1.10

0.12

1.4

1.3

—

47.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

218

1.09

0.11

2.0

2.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

238

1.08

0.10

1.3

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.15

0.10

1.6

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

174

0.91

0.09

5.0

7.7

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

265

0.93

0.09

1.0

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.12

0.09

1.3

3.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

112

0.88

0.09

1.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.04

0.08

1.0

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.81

0.08

2.6

5.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.10

0.08

6.7

5.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

517

5051

1.01

0.08

1.9

2.1

—

(3042631) Mycobacterium sp identified in Specimen

152

0.91

0.08

2.4

2.6

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

717

1.03

0.08

1.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.83

0.07

1.0

1.5

—

(3036071) Salmonella sp Ab [Titer] in Serum

193

1.07

0.07

1.0

1.1

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

1.07

0.07

2.1

1.5

mg/l

2.2

1.6

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.05

0.07

1.5

1.6

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

110

0.90

0.06

1.0

1.1

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

120

0.90

0.06

3.6

3.2

u/ml

18.9

43.3

1.05

120

(3047007) Chlamydophila sp Ab [Presence] in Serum

867

1.02

0.06

1.1

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

150

0.92

0.06

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

190

0.93

0.06

2.6

2.1

—

(3035933) Granulocytes/100 leukocytes in Blood

263

1.05

0.05

1.7

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

400

0.96

0.05

1.3

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

273

1.05

0.05

2.3

2.7

e6/l

329.1

246.1

0.51

166

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

254

1.05

0.05

1.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

245

1.05

0.04

1.3

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

862

1.02

0.04

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

148

1.07

0.04

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

148

1.07

0.04

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

148

1.07

0.04

1.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

497

0.97

0.04

1.4

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

785

0.98

0.04

2.7

2.6

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

316

1.03

0.03

1.1

1.2

ratio

1.0

1.1

—

126

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

111

1.07

0.02

1.0

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

672

1.01

0.01

1.1

115.1

114.4

0.07

604

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

422

0.98

0.01

1.0

1.1

iu/ml

7.5

6.9

0.05

(3041806) Other cells [#/volume] in Blood by Manual count

718

0.99

0.01

1.7

1.5

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

372

0.98

0.01

3.8

4.3

mg/l

8.7

8.6

0.03

304

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.06

0.00

1.1

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.06

0.00

1.1

1.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

124

0.96

0.00

2.1

3.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

261

1.02

0.00

1.4

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

115

1.03

0.00

1.1

1.3

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

120

0.99

0.00

1.0

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.03

0.00

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

235

1.01

0.00

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

112

0.97

0.00

1.0

1.1

—

(3037756) Immunofixation for Serum or Plasma

153

1.03

0.00

1.1

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

134

1.03

0.00

1.1

1.7

—

(21494434) Karyotype in Bone marrow

155

1.02

0.00

1.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

103

0.96

0.00

1.0

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

118

1.00

0.00

1.1

1.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

101

0.98

0.00

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

131

0.98

0.00

1.7

1.8

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

159

0.99

0.00

1.1

—

(3004451) EKG impression Narrative

0.85

0.00

1.0

1.2

—

(3001729) Color of Synovial fluid

0.00

0.0

1.9

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.5

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.1

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.0

2.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.0

1.3

—

(3017497) Pine Nut IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

7.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.0

1.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.0

—

2.7

—

(3018487) Sunflower Seed IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.95

0.00

1.0

1.1

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.0

2.0

—

(3014891) Appearance of Pleural fluid

0.00

0.0

1.7

—

(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

4.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.4

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

77.8

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

0.91

0.00

1.0

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

0.90

0.00

1.0

1.2

mmol/l

6.2

6.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.93

0.00

1.6

1.8

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.99

0.00

7.7

5.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.89

0.00

1.4

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.88

0.00

1.0

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.93

0.00

1.0

1.1

—

(3041198) Albumin [Mass/volume] in Peritoneal dialysis fluid

0.00

0.0

4.4

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

0.0

1.2

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.0

1.3

—

Mortality – FinRegistry

↥

Association

Association between endpoint F5_ADHD and mortality.

Females

Parameter	HR [95% CI]	p-value
F5_ADHD	2.553 [1.94, 3.36]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.18

During the follow-up period (1.1.1998 — 31.12.2019), 97 out of 14996 females with F5_ADHD died.

Males

Parameter	HR [95% CI]	p-value
F5_ADHD	2.559 [2.19, 2.99]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.013

During the follow-up period (1.1.1998 — 31.12.2019), 477 out of 37990 males with F5_ADHD died.

Mortality risk

Mortality risk for people of age

years, who have F5_ADHD.

N-year risk	Females	Males
1	0.212%	0.501%
5	1.36%	3.126%
10	3.513%	7.638%
15	6.563%	14.012%
20	11.821%	22.882%

Relationships between endpoints

↥

Index endpoint: F5_ADHD – Disturbance of activity and attention

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Disturbance of activity and attention

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints